Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome

Gene

Volumn 528, Issue 2, 2013, Pages 132-138

  Ye, Qing ^a   Zhao, Xu ^a   Xu, Kang ^a   Li, Qian ^b   Cheng, Jinluo ^c   Gao, Yanqin ^a   Du, Juan ^a   Shi, Hui ^a   Zhou, Ling ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Haplotype; Metabolic syndrome; MiRNA target binding sites; Single nucleotide polymorphism

Indexed keywords

FATTY ACID BINDING PROTEIN 2; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; TRIACYLGLYCEROL;

ADULT; ARTICLE; BINDING SITE; BIOINFORMATICS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

3'UNTRANSLATED REGIONS; 3'UTRS; AHA; AMERICAN HEART ASSOCIATION; BMI; BODY MASS INDEX; CI; CONFIDENCE INTERVAL; DBP; DIASTOLIC BLOOD PRESSURE; FASTING PLASMA GLUCOSE; FPG; HAPLOTYPE; HDL-C; HIGH DENSITY LIPOPROTEIN CHOLESTERIN; IDF; INTERNATIONAL DIABETES FEDERATION; LDA; LDL-C; LINKAGE DISEQUILIBRIUM ANALYSIS; LOW DENSITY LIPOPROTEIN CHOLESTERIN; MAF; METABOLIC SYNDROME; METS; MICRORNA; MINOR ALLELE FREQUENCY; MIRNA; MIRNA TARGET BINDING SITES; MIRNA-INDUCED SILENCING EFFECTOR COMPLEX; MRISC; NATIONAL CENTER OF BIOTECHNOLOGY INFORMATION; NATIONAL HEART, LUNG AND BLOOD INSTITUTE; NCBI; NHLBI; ODDS RATIO; OR; PCR; POLYMERASE CHAIN REACTION; SBP; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; SYSTOLIC BLOOD PRESSURE; T2DM; TC; TG; TOTAL CHOLESTEROL; TRIGLYCERIDE; TYPE 2 DIABETES MELLITUS; WAIST CIRCUMFERENCE; WC;

3' UNTRANSLATED REGIONS; ADULT; AGED; APOLIPOPROTEINS; BINDING SITES; CASE-CONTROL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84883054093     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.07.036     Document Type: Article

References (42)

1. Albala B.C., Jimenez R.B., Perez B.F., Liberman G.C. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance. Rev. Med. Chil. 2006, 134:372-379.
2. Alberti K.G., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
3. Aravin A.A., Hannon G.J., Brennecke J. The Piwi-piRNA pathway provides an adaptive defense in the transposon arms race. Science 2007, 318:761-764.
4. Bao L., et al. PolymiRTS database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Res. 2007, 35:D51-D54.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
7. Brendle A., et al. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis 2008, 29:1394-1399.
8. Chasman D.I., et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet. 2009, 5:e1000730.
9. Cheung K.J., et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab. 2007, 5:115-128.
10. Coyle J.T. MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2975-2976.
11. de Luca C., Olefsky J.M. Inflammation and insulin resistance. FEBS Lett. 2008, 582:97-105.
12. Eckel R.H., Alberti K.G., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2010, 375:181-183.
13. Esau C., et al. MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 2004, 279:52361-52365.
14. He A., Zhu L., Gupta N., Chang Y., Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 2007, 21:2785-2794.
15. He J., Xu X., Francisco A., Ferrante A., Krakoff J. Markers of adipose tissue macrophage content are negatively associated with serum HDL-C concentrations. Atherosclerosis 2011, 215:243-246.
16. Hiard S., Charlier C., Coppieters W., Georges M., Baurain D. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res. 2010, 38:D640-D651.
17. Iyer A., Kauter K., Brown L. Gender differences in metabolic syndrome: a key research issue?. Endocr. Metab. Immune Disord. Drug Targets 2011, 11:182-188.
18. Keller P., et al. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr. Disord. 2011, 11:1472-1483.
19. Kloting N., et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One 2009, 4:e4699.
20. Kontorovich T., Levy A., Korostishevsky M., Nir U., Friedman E. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int. J. Cancer 2010, 127:589-597.
21. Lei S.F., Papasian C.J., Deng H.W. Polymorphisms in predicted miRNA binding sites and osteoporosis. J. Bone Miner. Res. 2011, 26:72-78.
22. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
23. Liu Y.J., et al. Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity. Obesity (Silver Spring) 2010, 18:2339-2346.
24. Miyamoto Y., et al. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort. Diabetes Res. Clin. Pract. 2009, 85:132-138.
25. Moller D.E., Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 2005, 56:45-62.
26. Ortega Martinez de Victoria E., et al. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 2009, 58:385-393.
27. Ortega F.J., et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 2010, 5:e9022.
28. Phillips C.M., et al. Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndrome. J. Lipid Res. 2010, 51:1793-1800.
29. Pollex R.L., Hegele R.A. Genetic determinants of the metabolic syndrome. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3:482-489.
30. Reinhart B.J., Bartel D.P. Small RNAs correspond to centromere heterochromatic repeats. Science 2002, 297:1831.
31. Satzger I., et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer 2010, 126:2553-2562.
32. Sibbel S.P., et al. RGS6 variants are associated with dietary fat intake in Hispanics: the IRAS family study. Obesity (Silver Spring) 2011, 19:1433-1438.
33. Takanabe R., et al. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem. Biophys. Res. Commun. 2008, 376:728-732.
34. Teuber M., Wenz M.H., Schreiber S., Franke A. GMFilter and SXTestPlate: software tools for improving the SNPlex genotyping system. BMC Bioinformatics 2009, 10:81.
35. Wang H., Gauthier B.R., Hagenfeldt-Johansson K.A., Iezzi M., Wollheim C.B. Foxa2 (HNF3beta) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J. Biol. Chem. 2002, 277:17564-17570.
36. Wang G., et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 2008, 82:283-289.
37. Wilfred B.R., Wang W.X., Nelson P.T. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 2007, 91:209-217.
38. Xie H., Lim B., Lodish H.F. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009, 58:1050-1057.
39. Yang Z., Kaye D.M. Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension. Hum. Mutat. 2009, 30:328-333.
40. Yang F., et al. An ARC/mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 2006, 442:700-704.
41. Zhao Z.Z., et al. Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis. Mol. Hum. Reprod. 2011, 17:92-103.
42. Zhaorigetu S., Yang Z., Toma I., McCaffrey T.A., Hu C.A. Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin 1-dependent autophagy in atherosclerotic cells. J. Biol. Chem. 2011, 286:27389-27398.